 | • レポートコード：MRC2012A9833 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、7価肺炎球菌ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。7価肺炎球菌ワクチンの種類別市場規模（単回投与バイアル、プレフィルドシリンジ）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、 ・地域別グローバル市場分析 2015年-2020年 ・7価肺炎球菌ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・7価肺炎球菌ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・7価肺炎球菌ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・7価肺炎球菌ワクチンの南米市場（ブラジル、アルゼンチン） ・7価肺炎球菌ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：単回投与バイアル、プレフィルドシリンジ ・用途別分析：病院、クリニック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global 7-Valent Pneumococcal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The 7-Valent Pneumococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
7-Valent Pneumococcal Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, 7-Valent Pneumococcal Vaccine market has been segmented into
Single Dose Vial
Pre-filled Syringe
By Application, 7-Valent Pneumococcal Vaccine has been segmented into:
Hospital
Clinic
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global 7-Valent Pneumococcal Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level 7-Valent Pneumococcal Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global 7-Valent Pneumococcal Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the 7-Valent Pneumococcal Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and 7-Valent Pneumococcal Vaccine Market Share Analysis
7-Valent Pneumococcal Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, 7-Valent Pneumococcal Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the 7-Valent Pneumococcal Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in 7-Valent Pneumococcal Vaccine are:
Merck
Among other players domestic and global, 7-Valent Pneumococcal Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 7-Valent Pneumococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of 7-Valent Pneumococcal Vaccine, with price, sales, revenue and global market share of 7-Valent Pneumococcal Vaccine in 2018 and 2019.
Chapter 3, the 7-Valent Pneumococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 7-Valent Pneumococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, 7-Valent Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe 7-Valent Pneumococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 7-Valent Pneumococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global 7-Valent Pneumococcal Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Market Analysis by Application
1.3.1 Overview: Global 7-Valent Pneumococcal Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.4 Overview of Global 7-Valent Pneumococcal Vaccine Market
1.4.1 Global 7-Valent Pneumococcal Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck 7-Valent Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global 7-Valent Pneumococcal Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global 7-Valent Pneumococcal Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 7-Valent Pneumococcal Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 7-Valent Pneumococcal Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global 7-Valent Pneumococcal Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global 7-Valent Pneumococcal Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global 7-Valent Pneumococcal Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.5 South America 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America 7-Valent Pneumococcal Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America 7-Valent Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America 7-Valent Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe 7-Valent Pneumococcal Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe 7-Valent Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe 7-Valent Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.3 UK 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.4 France 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific 7-Valent Pneumococcal Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific 7-Valent Pneumococcal Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific 7-Valent Pneumococcal Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.5 India 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America 7-Valent Pneumococcal Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America 7-Valent Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America 7-Valent Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global 7-Valent Pneumococcal Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global 7-Valent Pneumococcal Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global 7-Valent Pneumococcal Vaccine Price by Type (2015-2020)
11 Global 7-Valent Pneumococcal Vaccine Market Segment by Application
11.1 Global 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
11.2 Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global 7-Valent Pneumococcal Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global 7-Valent Pneumococcal Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 7-Valent Pneumococcal Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America 7-Valent Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.2 Europe 7-Valent Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific 7-Valent Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.4 South America 7-Valent Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa 7-Valent Pneumococcal Vaccine Market Forecast (2021-2025)
12.3 7-Valent Pneumococcal Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global 7-Valent Pneumococcal Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global 7-Valent Pneumococcal Vaccine Market Share Forecast by Type (2021-2025)
12.4 7-Valent Pneumococcal Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global 7-Valent Pneumococcal Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global 7-Valent Pneumococcal Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global 7-Valent Pneumococcal Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of 7-Valent Pneumococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global 7-Valent Pneumococcal Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck 7-Valent Pneumococcal Vaccine Major Business
Table 9. Merck 7-Valent Pneumococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Merck SWOT Analysis
Table 11. Merck 7-Valent Pneumococcal Vaccine Product and Services
Table 12. Merck 7-Valent Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Global 7-Valent Pneumococcal Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 14. Global 7-Valent Pneumococcal Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 15. Global 7-Valent Pneumococcal Vaccine Sales by Regions (2015-2020) (K Units)
Table 16. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Regions (2015-2020)
Table 17. Global 7-Valent Pneumococcal Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 18. North America 7-Valent Pneumococcal Vaccine Sales by Countries (2015-2020) (K Units)
Table 19. North America 7-Valent Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 20. North America 7-Valent Pneumococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 21. North America 7-Valent Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Table 22. Europe 7-Valent Pneumococcal Vaccine Sales by Countries (2015-2020) (K Units)
Table 23. Europe 7-Valent Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 24. Europe 7-Valent Pneumococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 25. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales by Regions (2015-2020) (K Units)
Table 26. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales Market Share by Regions (2015-2020)
Table 27. Asia-Pacific 7-Valent Pneumococcal Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 28. South America 7-Valent Pneumococcal Vaccine Sales by Countries (2015-2020) (K Units)
Table 29. South America 7-Valent Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 30. South America 7-Valent Pneumococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 31. South America 7-Valent Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Table 32. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Countries (2015-2020) (K Units)
Table 33. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 34. Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 35. Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Table 36. Global 7-Valent Pneumococcal Vaccine Sales by Type (2015-2020) (K Units)
Table 37. Global 7-Valent Pneumococcal Vaccine Sales Share by Type (2015-2020)
Table 38. Global 7-Valent Pneumococcal Vaccine Revenue by Type (2015-2020) (USD Million)
Table 39. Global 7-Valent Pneumococcal Vaccine Revenue Share by Type (2015-2020)
Table 40. Global 7-Valent Pneumococcal Vaccine Sales by Application (2015-2020) (K Units)
Table 41. Global 7-Valent Pneumococcal Vaccine Sales Share by Application (2015-2020)
Table 42. Global 7-Valent Pneumococcal Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 43. Global 7-Valent Pneumococcal Vaccine Market Share Forecast by Regions (2021-2025)
Table 44. Global 7-Valent Pneumococcal Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 45. Global 7-Valent Pneumococcal Vaccine Market Share Forecast by Type (2021-2025)
Table 46. Global 7-Valent Pneumococcal Vaccine Sales Forecast by Application (2021-2025)
Table 47. Global 7-Valent Pneumococcal Vaccine Market Share Forecast by Application (2021-2025)
Table 48. Direct Channel Pros & Cons
Table 49. Indirect Channel Pros & Cons
Table 50. Distributors/Traders/ Dealers List
List of Figures
Figure 1. 7-Valent Pneumococcal Vaccine Picture
Figure 2. Global Sales Market Share of 7-Valent Pneumococcal Vaccine by Type in 2019
Figure 3. Single Dose Vial Picture
Figure 4. Pre-filled Syringe Picture
Figure 5. 7-Valent Pneumococcal Vaccine Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Global 7-Valent Pneumococcal Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey 7-Valent Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Manufacturer in 2019
Figure 29. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 7-Valent Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 7-Valent Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Regions (2015-2020)
Figure 36. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Regions in 2018
Figure 37. North America 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 38. Europe 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 40. South America 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 42. North America 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America 7-Valent Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Figure 44. North America 7-Valent Pneumococcal Vaccine Sales Market Share by Countries in 2018
Figure 45. North America 7-Valent Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America 7-Valent Pneumococcal Vaccine Revenue Market Share by Countries in 2018
Figure 47. United States 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe 7-Valent Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe 7-Valent Pneumococcal Vaccine Revenue Market Share by Countries in 2019
Figure 53. Germany 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific 7-Valent Pneumococcal Vaccine Revenue Market Share by Regions 2019
Figure 61. China 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America 7-Valent Pneumococcal Vaccine Sales Market Share by Countries in 2019
Figure 68. South America 7-Valent Pneumococcal Vaccine Revenue Market Share by Countries in 2019
Figure 69. Brazil 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa 7-Valent Pneumococcal Vaccine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa 7-Valent Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa 7-Valent Pneumococcal Vaccine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global 7-Valent Pneumococcal Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales 7-Valent Pneumococcal Vaccine Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales 7-Valent Pneumococcal Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales 7-Valent Pneumococcal Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales 7-Valent Pneumococcal Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales 7-Valent Pneumococcal Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
9価HPVワクチン（9vHPV）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The 9-valent HPV Vaccine (9vHPV) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 子宮頸がんワクチンの世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Vaccine Market The global Cervical Cancer Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cervical Cancer Vaccine Scope and Market Size Cervical Cancer Vacci…
- 肺炎球菌ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Pneumococcal Vaccines Market The global Pneumococcal Vaccines market size is projected to reach US$ 7121.8 million by 2026, from US$ 7038.2 million in 2020, at a CAGR of 1.1%% during 2021-2026. Global Pneumococcal Vaccines Scope and Market Size Pneumococcal Vacci…
- ワクチン＆薬用ガラス瓶の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Vaccine & Medicine Glass Bottles market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- ヒト用ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Human Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…